Düzce Keleş Ela, Birtane Murat, Ekuklu Galip, Kılınçer Cumhur, Çalıyurt Okan, Taştekin Nurettin, Is Enes Efe, Ketenci Ayşegül, Neblett Randy
Department of Physical Medicine and Rehabilitation, Yatagan State Hospital, Muğla, Turkey.
Department of Physical Medicine and Rehabilitation, Trakya University Medical Faculty, Edirne, Turkey.
Arch Rheumatol. 2021 Oct 18;36(4):518-526. doi: 10.46497/ArchRheumatol.2022.8665. eCollection 2021 Dec.
The aim of this study was to translate the Central Sensitization Inventory (CSI) into the Turkish language, to perform a psychometric validation, and to investigate its reliability in patients with chronic spinal pain with an organic origin, patients with fibromyalgia, and pain-free control individuals.
Between April 2016 and February 2017, the translation of the original English version of the CSI into Turkish was performed using the forward-backward translation method. A total of 100 fibromyalgia patients (6 males, 94 females; mean age: 45.0±8.4 years; range, 25 to 60 years), 100 patients with chronic spinal pain with an identified organic origin (CSPO), (10 males, 90 females; mean age: 43.8±9.7 years; range, 21 to 60 years), and 100 healthy controls (8 males, 92 females; mean age: 35.8±10.1 years; range, 25 to 55 years) were included in the study. Demographic characteristics were collected. Test-retest reliability was determined by re-administering the CSI-Turkish (CSI-Turk) two weeks after the first application.
The internal consistency (Cronbach's alpha) was found to be 0.92 and the intraclass correlation coefficient was 0.93. Patients with fibromyalgia, a very common central sensitivity syndrome (CSS), had the highest mean CSI-Turk scores, and healthy controls had the lowest. Using the recommended cut-off score of 40 resulted in 87% sensitivity and 90% specificity in distinguishing between fibromyalgia and control individuals.
This study suggests that the CSI-Turk can be effectively used as a screening tool to elucidate CS-related symptomology among patients with chronic pain with a high internal consistency, test-retest reliability, sensitivity, and specificity.
本研究旨在将中枢敏化量表（CSI）翻译成土耳其语，进行心理测量学验证，并调查其在患有器质性慢性脊柱疼痛的患者、纤维肌痛患者和无疼痛对照个体中的可靠性。
2016年4月至2017年2月期间，采用正向-反向翻译法将CSI的原始英文版翻译成土耳其语。共有100例纤维肌痛患者（6例男性，94例女性；平均年龄：45.0±8.4岁；范围，25至60岁）、100例已确定有器质性病因的慢性脊柱疼痛患者（CSPO）（10例男性，90例女性；平均年龄：43.8±9.7岁；范围，21至60岁）和100例健康对照者（8例男性，92例女性；平均年龄：35.8±10.1岁；范围，25至55岁）纳入研究。收集人口统计学特征。通过在首次应用两周后重新施用土耳其语版CSI（CSI-Turk）来确定重测信度。
发现内部一致性（Cronbach's α）为0.92，组内相关系数为0.93。纤维肌痛患者是一种非常常见的中枢敏感性综合征（CSS），其CSI-Turk平均得分最高，健康对照者得分最低。使用推荐的临界值40在区分纤维肌痛患者和对照个体时，敏感性为87%，特异性为90%。
本研究表明，CSI-Turk具有较高的内部一致性、重测信度、敏感性和特异性，可有效用作筛查工具，以阐明慢性疼痛患者中与中枢敏化相关的症状学。
